The identification of quality antibacterial drug discovery targets: A case study with aminoacyl-tRNA synthetases

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 1, 2000, Pages 1-9

  Gallant, Paul ^b   Finn, John ^a   Keith, Dennis ^a   Wendler, Philip ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

aminoacyl tRNA synthetases; antibiotics; high throughput screening; protein sequence homology; quality targets; target based drug discovery

Indexed keywords

EID: 80051995882     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.1.1     Document Type: Review

References (27)

1. GOLD HS, MOELLERING RC: Antimicrobial-drug resistance. N. Engl. J. Med. (1996) 335:1445-1453.
2. RUBIN RJ, HARRINGTON CA, POON A, DIETRICH K, GREENE JA, MOIDUDDIN A: The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. (1999) 5:9-17. (Pubitemid 29124770)
3. EDMOND MB, OBER JF, DAWSON JD, WEINBAUM DL, WENZEL RP: Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. (1996) 23:1234-1239. (Pubitemid 26423158)
4. CENTERS FOR DISEASE CONTROL AND PREVENTION: Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan. Morbid. Mortal. Weekly Rep. (1997) 46:624-626.
5. CENTERS FOR DISEASE CONTROL AND PREVENTION: Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morbid. Mortal. Weekly Rep. (1997) 46:765-766.
6. SILVER LL, BOSTIAN KA: Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob. Agents Chemother. (1993) 37(3):377-383. (Pubitemid 23072576)
7. BRYSKIER A: Novelties in the field of anti-infectives in .1997. Clin. Infect. Dis. (1998) 27:865-883.
8. LABIA R, BARTHELEMY M, PEDUZZI J, MORANDI A, TIWARI K, KAZMIERCZAK A: Overcoming enzymatic resistance in bacteria: impact on future therapy. J. Int. Med. Res. (1990) 18:48D-57D.
9. GROSH WW, QUESENBERRY PJ: Recombinant human hematopoietic growth factors in the treatment of cytopenias. Clin. Immunol. Immunopathol. (1992) 62:S25-S38.
10. BLATTNER FR, PLUNKETT G III, BLOCH CA et al.: The complete genome sequence of Escherichia coli K-12. Science (1997) 277:1453-1462. (Pubitemid 27449228)
11. FLEISCHMANN RD, ADAMS MD, WHITE O et al.: Wholegenome random sequencing and assembly of Haemophilus influenzae Rd. Science (1995) 269:496-512.
12. MOIR DT, SHAW KJ, HARE RS, VOVIS GF: Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. (1999) 43(3):439-446. (Pubitemid 29109500)
13. SCHIMMEL P, TAO J, HILL J: Aminoacyl tRNA synthetases as targets for new anti-infectives. FASEB J. (1998) 12:1599-1609. (Pubitemid 28553655)
14. ERIANI G, DELARUE M, POCH O, GANGLOFF J, MORAS D: Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature (1990) 347:203-206.
15. SCHIMMEL P: Classes of aminoacyl-tRNA synthetases and the establishment of the genetic code. Trends Biochem. Sci. (1991) 16:1-3. (Pubitemid 121004392)
16. BURBAUM JJ, SCHIMMEL P: Structural relationships and the classification of aminoacyl-tRNA synthetases. J. Biol. Chem. (1991) 266:16965-16968. (Pubitemid 21907889)
17. WEBSTER TA, TSAI H, KULA M, MACKIE GA, SCHIMMEL P: Specific sequence homology and three-dimensional structure of an aminoacyl transfer RNA synthetase. Science (1984) 226:1315-1317. (Pubitemid 15215582)
18. HOUNTONDJI C, DESSEN P, BLANQUET S: Sequence similarities among the family of aminoacyl-tRNA synthetases. Biochemie (1986) 68:1071-1078. (Pubitemid 16003667)
19. LUDMERER SW, SCHIMMEL P: Gene for yeast glutamine tRNA synthetase encodes a large amino terminal extension and provides strong confirmation of the signature sequence for a group of aminoacyl tRNA synthetases. J. Biol. Chem. (1987) 262:10801-10806.
20. MORAS D: Structural and functional relationships between aminoacyl-tRNA synthetases. Trends Biochem. Sci. (1992) 17:159-164.
21. CUSACK S, BERTHET-COLOMINAS C, HARTLEIN M, NASSAR N, LEBERMAN R: A second class of synthetase structure revealed by X-ray analysis of Escherichia coli seryl-tRNA synthetase at 2.5A. Nature (1990) 347:249-255.
22. HUGHES J, MELLOWS G: Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem. J. (1978) 176:305-318. (Pubitemid 9060536)
23. HUGHES J, MELLOWS G: Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem. J. (1980) 191:209-219. (Pubitemid 11198152)
24. HUGHES J, MELLOWS G, SOUGHTON S: How does Pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide? FEBS Lett. (1980) 122(2):322-324. (Pubitemid 11186283)
25. WERNER RG, THORPE LF, REUTER W, NIERHAUS KH: Indolmycin inhibits prokaryotic tryptophan-tRNA ligase. Eur. J. Biochem. (1976) 68(1):1-3.
26. LEHNINGER AL: The amino acid building blocks of proteins. In: Biochemistry. Worth Publishers, New York, USA (1975):71-94.
27. LANDES C, PERONA JJ, BRUNIE S et al.: A structure-based multiple sequence alignment of all class I aminoacyltRNA synthetases. Biochemie (1995) 77:194-203.